# Valorization of ligustrum species: biosynthesis, metabolic engineering, and pharmacology of bioactive compounds

**Authors:** Dipeng Li, Chenyang Lu, Yan Zhang, Yunfei Yu, Chenghao Fei, Peng Chen, Rao Fu, Mao Wu, Peina Zhou

PMC · DOI: 10.1186/s40643-026-01042-3 · Bioresources and Bioprocessing · 2026-03-27

## TL;DR

This paper reviews the medicinal and economic potential of Ligustrum plants, focusing on their bioactive compounds and sustainable production methods.

## Contribution

The paper proposes an integrated approach combining omics, synthetic biology, and sustainable manufacturing for Ligustrum valorization.

## Key findings

- Ligustrum species contain diverse bioactive compounds with anti-inflammatory, antioxidant, and antitumor effects.
- Omics-based analyses and metabolic engineering are key for sustainable production of Ligustrum-derived metabolites.
- The review suggests a framework for whole-plant valorization and germplasm conservation.

## Abstract

The genus Ligustrum (Oleaceae) encompasses woody plants with both medicinal and edible uses, distinguished by a wide range of bioactive compounds, including triterpenoids, phenylethanoid glycosides, flavonoids, and other active constituents. These metabolites demonstrate multi-target pharmacological effects, such as anti-inflammatory, antioxidant, antitumor, and anti-osteoporotic activities. In traditional medicine, species like L. lucidum and L. robustum are well-documented for their therapeutic roles in nourishing the liver and kidneys, enhancing vision, darkening hair, and serving as functional tea ingredients. Beyond their medicinal and health-promoting properties, Ligustrum species are also employed as ornamental plants, bioindicators of atmospheric pollution, algicidal agents, and feed additives. Given the increasing global demand and underutilization of Ligustrum resources, there is an urgent need to establish a sustainable supply framework focused on alternative strategies such as metabolic engineering, synthetic biology, and environmentally friendly manufacturing. This review encapsulates recent progress in the exploration of chemical diversity, pharmacological characteristics, omics-based analyses, and biosynthetic research pertaining to Ligustrum. It proposes an integrated methodology that amalgamates multi-omics approaches, synthetic biology, and environmentally sustainable manufacturing processes to advance strategies for whole-plant valorization and germplasm conservation. The objective is to establish a theoretical framework and technical paradigm to facilitate the comprehensive exploitation and sustainable utilization of Ligustrum as a medicinal resource.

## Linked entities

- **Chemicals:** triterpenoids (PubChem CID 71597391)
- **Species:** Ligustrum lucidum (taxon 458695), Ligustrum robustum (taxon 1028359)

## Full-text entities

- **Genes:** MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, ERG10 (acetyl-CoA C-acetyltransferase) [NCBI Gene 856079] {aka LPB3, TSM0115}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, CCND1 (cyclin D1) [NCBI Gene 595] {aka BCL1, D11S287E, PRAD1, U21B31}, ERG8 (phosphomevalonate kinase) [NCBI Gene 855260], PTEN (phosphatase and tensin homolog) [NCBI Gene 5728] {aka 10q23del, BZS, CWS1, DEC, GLM2, MHAM}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, ERG13 (hydroxymethylglutaryl-CoA synthase) [NCBI Gene 854913] {aka HMGS}, Ctnnb1 (catenin beta 1) [NCBI Gene 84353] {aka Catnb}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, TIMP2 (TIMP metallopeptidase inhibitor 2) [NCBI Gene 7077] {aka CSC-21K, DDC8}, ERG12 (mevalonate kinase) [NCBI Gene 855248] {aka RAR1}, ERG1 (squalene monooxygenase) [NCBI Gene 853086], ARO10 (phenylpyruvate decarboxylase ARO10) [NCBI Gene 851987], CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, CDK4 (cyclin dependent kinase 4) [NCBI Gene 1019] {aka CMM3, MCPH31, PSK-J3}, Mmp13 (matrix metallopeptidase 13) [NCBI Gene 171052], ADH6 (NADP-dependent alcohol dehydrogenase) [NCBI Gene 855368] {aka ADHVI}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, Wnt2 (Wnt family member 2) [NCBI Gene 114487] {aka Wnt}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}
- **Diseases:** tumor (MESH:D009369), fibrosis (MESH:D005355), hypoglycemic (MESH:C000721848), hepatocellular damage (MESH:D056486), metabolic disorder (MESH:D008659), hyperlipidemia (MESH:D006949), mechanical allodynia (MESH:D006930), joint pain hypersensitivity (MESH:D018771), inflammation (MESH:D007249), MIA (MESH:C562377), chronic pain (MESH:D059350), OP (MESH:D010024), breast or lung cancer (MESH:D001943), hyperglycemia (MESH:D006943), LRTPG (MESH:D011017), T2DM (MESH:D003924), obesity (MESH:D009765), depressive (MESH:D003866), osteoporotic (MESH:D058866), bone loss (MESH:D001847), diabetic complications (MESH:D048909), insulin resistance (MESH:D007333), OMES (MESH:D015217), dyslipidemia (MESH:D050171), SQS (MESH:D020159), OA (MESH:D010003), degenerative joint disorder (MESH:D019636), colorectal cancer (MESH:D015179), DM (MESH:D003920), hepatocellular carcinoma (MESH:D006528), neuroinflammation (MESH:D000090862), PD (MESH:D010300), IPP (MESH:C563162), cytotoxic (MESH:D064420)
- **Chemicals:** blood glucose (MESH:D001786), iridoid (MESH:D039823), luteolin (MESH:D047311), naringenin (MESH:C005273), 2-C-Methyl-D-erythritol 4-phosphate (MESH:C114232), Nepetalactol (MESH:C497341), ginsenoside Rh2 (MESH:C055305), tyrosol (MESH:C011867), 4-HPAA (MESH:C097891), dammarane (MESH:C102963), salt (MESH:D012492), lupane (MESH:C480546), rutin (MESH:D012431), ROS (MESH:D017382), saponin (MESH:D012503), ester (MESH:D004952), apigenin (MESH:D047310), diterpenes (MESH:D004224), iso-liquiritin apioside (MESH:C084321), monoterpenes (MESH:D039821), 7-deoxyloganic acid (MESH:C432876), Geranyl pyrophosphate (MESH:C015234), hydroxytyrosol (MESH:C005975), nuezhenide (MESH:C083178), quercetin (MESH:D011794), FPP (MESH:C004808), L-tyrosine (MESH:D014443), LF (MESH:C405585), glucose (MESH:D005947), volatile oils (MESH:D009822), L-3,4-dihydroxyphenylalanine (MESH:D007980), sugar (MESH:D000073893), tyramine (MESH:D014439), water (MESH:D014867), FFA (MESH:D005230), vitamin D (MESH:D014807), crocin (MESH:C029036), echinacoside (MESH:C060297), LPS (MESH:D008070), oleuropein (MESH:C002769), sesquiterpenes (MESH:D012717), acetyl-CoA (MESH:D000105), Flavonoids (MESH:D005419), Phenethyl alcohol (MESH:D010626), oleic acid (MESH:D019301), MIA (MESH:D019807), alloxan (MESH:D000496), QS-7 (MESH:C112621), oleanane (MESH:C413246), beta-elemene (MESH:C445979), ligupurpuroside A (MESH:C000598661), Salidroside (MESH:C009172), Ethanol (MESH:D000431), isoprenoid (MESH:D013729), pentacyclic triterpenoids (MESH:D053978), taxol (MESH:D017239), beta-amyrin (MESH:C036380), geraniol (MESH:C007836), ursane (MESH:C000606873), phenolic acid (MESH:C017616)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Glycyrrhiza uralensis (Chinese licorice, species) [taxon 74613], L. japonicum [taxon 94989], Pantoea ananatis (species) [taxon 553], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Escherichia coli (E. coli, species) [taxon 562], Cricetinae (hamsters, subfamily) [taxon 10026], Nicotiana benthamiana (species) [taxon 4100], Mus musculus (house mouse, species) [taxon 10090], Yarrowia lipolytica (species) [taxon 4952], Rhodiola crenulata (da hua hong jing tian, species) [taxon 242839], Ligustrum vulgare (common privet, species) [taxon 13597], Ligustrum delavayanum (species) [taxon 947956], Lasiospermum pedunculare (species) [taxon 457720], Nicotiana tabacum (American tobacco, species) [taxon 4097], Ligustrum robustum (species) [taxon 1028359], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** L in 5, S577A, G10H, L in 10, A21G
- **Cell lines:** RAW264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), Hh-7 — Homo sapiens (Human), Transformed cell line (CVCL_HC63), Bel-7402 — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_5492), BMSC — Oryctolagus cuniculus (Rabbit), Finite cell line (CVCL_B6BB)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13022168/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13022168/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC13022168/full.md

---
Source: https://tomesphere.com/paper/PMC13022168